Date Rape Drugs Still Available, Despite Crackdown
Five years after the fatal poisoning of Michigan teen Samantha Reid by a so-called date-rape drug, these types of narcotics remain widely available in the United States despite crackdowns.
Drugs
Latest in Drugs
Morning After Pills May Become as Available as 911
Two advisory panels for the Food and Drug Administration recommended this week in a 23-4 vote that Plan B–an intensive, short-term dose of birth control pills known as the morning after pill–be made available over the counter.
Barbara Seaman: Muckraker for Women’s Health
Barbara Seaman has made a career out of investigating the health hazards of hormonal medicine. In our Journalist of the Month profile, we look at what inspired her work and the success of her efforts.
College Students React to History of the Pill
Women’s History Month Special Feature: College students react to the PBS documentary chronicling the development of the pill.
Happy Birthday, Rosa Parks!
Civil rights leader Rosa Parks turns ninety during the first week of February, black history month. Her philosophy of freedom and equality for all people is as relevant today as the day she refused to give up her seat on an Alabama bus.
Feds Label Estrogen a ‘Known Carcinogen’
A new government ruling that estrogen is a cancer-causing agent is causing some health and environmental experts to ask if the hormone is overused. Also, the new U.S. Senator from Alaska is pro-choice Republican Lisa Murkowski.
Anti-Cancer Vaccine Could Shield More Women Abroad
Women and girls in developing countries are likely to benefit most from the new cervical cancer vaccine, but reaching them will be difficult. Also, advocates spar at the final public hearing on Title IX over the “proportionality” rule.
Estrogen Replacement May Douse Desire
Recent coverage of the merits and risks of hormone-replacement therapy hasn’t answered the question of how the treatment affects sexual desire. Evidence suggests the therapy may dampen a woman’s libido.
Feds May Track Sex Differences in Drug Reactions
Scientists, finding more evidence that women and men respond differently to drug trials, are pushing the government to create a permanent, national database of gender-based differences in pharmaceuticals.
